ADHD’s three distinct subtypes were first recognized in the 1994 update to the DSM (Diagnostic and Statistical Manual), however confusion over the subtypes’ differences persists even today. This appears particularly true of the “Predominantly Inattentive” (PI) subtype, which is characterized by symptoms of distractibility, failure to complete work, forgetfulness, and disorganization. People with the predominantly inattentive ADHD — many of them women diagnosed later in life — experience the same problems paying attention that are typical of ADHD, but they face fewer of the difficulties related to impulse control seen in the Combined subtype.

Because inattentive children exhibit fewer behavior-management problems, PI is not always recognized and diagnosed in childhood, and this under-recognition can persist into adulthood. This is particularly true for girls with ADHD, who are more likely than boys to have the PI subtype. Research and clinical experience show clearly, however, that difficulties with attention — even when not accompanied by impulsivity or hyperactivity — can lead to significant functional impairment and distress in higher education, the workplace, and in social

interactions. When PI is diagnosed and treated early, individuals can work to manage symptoms and take better control of the condition.

In this webinar, you will learn about:

The prevalence of predominantly inattentive ADHD in children and adults
The most common symptoms and distinctive features of inattentive ADHD
How predominantly inattentive ADHD is recognized and diagnosed
The daily-life difficulties of people with PI
Effective treatments for predominantly inattentive ADHD

Not available January 10? Don’t worry. Register now and we’ll send you the replay link to watch at your convenience.

Have a question for our expert? There will be an opportunity to post questions for the presenter during the live webinar.

Meet the Expert Speaker:
Dr. Mary Solanto is professor of pediatrics and psychiatry at the Hofstra/Northwell School of Medicine (Long Island, N.Y.). Prior to joining Hofstra, she was Director of the ADHD Center at the Mount Sinai School of Medicine and Associate Professor of Psychiatry at NYU. In 2017-2018, Dr. Solanto was a Fulbright U.S. Scholar in the Netherlands, where she conducted research on treatment of ADHD in college students. Dr. Solanto’s research on the cognitive and behavioral functioning of children and adults with ADHD, the effects of psychostimulants, and the characteristics of subtypes of ADHD has been supported by grants from NIMH, NICHD, and NINDS. She developed a novel cognitive-behavioral intervention for adults with ADHD, which was the focus of an NIMH-sponsored efficacy study (American Journal of Psychiatry, 2010). The manual for therapists, Cognitive-Behavioral Treatment of Adult ADHD: Targeting Executive Dysfunction was published by Guilford Press (2011). The program was recognized as the Innovative Program of the Year by CHADD (2011). Dr. Solanto has served on study section/grant review panels for NIMH. Currently, she is a member of the editorial boards of the Journal of Attention Disorders, and the ADHD Report (Guilford Press), and serves on the professional advisory boards of CHADD and APSARD.

Click here to register.